CONTINUING EDUCATION ACTIVITYNonpharmacologic Treatment of Pain in Sickle Cell DiseaseCoco, Megan MS, RN, APRNAuthor Information Ms. Coco is a Doctoral Student, Center for Advancement in Managing Permanent change Pain, University of Connecticut School of Nursing, 231 Glenbrook Rd, Storrs, CT 06269; E-mail: firstname.lastname@example.org. The purpose of this article is to review nonpharmacologic pain treatment options for patients with sickle cell disease.The author, faculty, and staff in a position to control the content of this CME/CNE activity have disclosed that they and their spouses/life partners (if any) have no financial relationships with, or financial interests in, any commercial organizations relevant to this educational activity.CME AccreditationLippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 70% of the quiz questions correctly. This CME activity expires on November 30, 2020.CNE AccreditationLippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Lippincott Professional Development will award 1.0 contact hours for this continuing nursing education activity. Instructions for earning ANCC contact hours are included on page 11 of the newsletter. This CNE activity expires on December 4, 2020. Topics in Pain Management: December 2018 - Volume 34 - Issue 5 - p 1-8 doi: 10.1097/01.TPM.0000549768.92473.6d Buy Take the CE Test Metrics © 2018 Wolters Kluwer Health, Inc. All rights reserved.